Rossari Biotech
Ticker >

Rossari Biotech share price

Rossari Biotech Ltd.

NSE: ROSSARI BSE: 543213 SECTOR: Chemicals  101k   715   119

760.85
+4.70 (0.62%)
NSE: Today, 04:11 PM

Price Summary

Today's High

₹ 771.95

Today's Low

₹ 750.05

52 Week High

₹ 903.85

52 Week Low

₹ 656.95

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4203.39 Cr.

Enterprise Value

₹ 4187.51 Cr.

No. of Shares

5.52 Cr.

P/E

43.51

P/B

4.5

Face Value

₹ 2

Div. Yield

0.07 %

Book Value (TTM)

₹  169.05

CASH

₹ 80.79 Cr.

DEBT

₹ 64.92 Cr.

Promoter Holding

68.32 %

EPS (TTM)

₹  17.49

Sales Growth

-9.1%

ROE

8.73 %

ROCE

11.74%

Profit Growth

-10.17 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-9.1%
3 Year17.57%
5 Year27.29%

Profit Growth

1 Year-10.17%
3 Year2.9%
5 Year19.81%

ROE%

1 Year8.73%
3 Year15.08%
5 Year24.27%

ROCE %

1 Year11.74%
3 Year19.66%
5 Year30.71%

Debt/Equity

0.0759

Price to Cash Flow

36.98

Interest Cover Ratio

21.7113469034214

CFO/PAT (5 Yr. Avg.)

0.955722314359554

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 68.32 0
Dec 2023 68.33 0
Sep 2023 68.35 0
Jun 2023 68.43 0
Mar 2023 68.43 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 17.5673177154771% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 21.7113469034214.
  • The company has an efficient Cash Conversion Cycle of 42.7408703445316 days.
  • The company has a high promoter holding of 68.32%.

 Limitations

  • The company has shown a poor profit growth of 2.90032478203914% for the Past 3 years.
  • The company is trading at a high PE of 43.51.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 236.9 263.64 258.34 332.01 298.75
Total Expenditure 204.98 227.85 223.21 289.67 257.61
Operating Profit 31.92 35.79 35.14 42.34 41.14
Other Income 0.25 2.32 1.34 1.96 2.13
Interest 1.76 1.16 1.88 2.54 2.63
Depreciation 6.68 6.72 5.51 6.26 5.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 23.73 30.23 29.09 35.5 34.8
Tax 6.27 7.09 7.53 9.12 9.26
Profit After Tax 17.46 23.14 21.56 26.38 25.54
Adjusted EPS (Rs) 3.17 4.2 3.91 4.78 4.62

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 515.92 600.09 690.41 1072.84 975.17
Total Expenditure 438.28 495.09 569.56 953.12 855.07
Operating Profit 77.64 105.01 120.86 119.72 120.11
Other Income 1.27 3.63 10.21 15.77 6.14
Interest 3.27 3.68 2.99 2.55 4.62
Depreciation 12.19 16.85 22.07 26.27 25.98
Exceptional Items 0 0 0 0 0
Profit Before Tax 63.45 88.11 106 106.68 95.65
Tax 17.66 22.59 26.9 27.21 24.26
Net Profit 45.79 65.52 79.1 79.47 71.39
Adjusted EPS (Rs.) 9.46 12.91 15.23 14.44 12.94

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4.4 10.15 10.39 11.01 11.03
Total Reserves 115.94 273.32 394.06 773.51 847.67
Borrowings 0.67 33.96 0 0 34.93
Other N/C liabilities 36.51 35.11 57.68 56.95 56.25
Current liabilities 123.91 168.83 165.62 191.08 305.82
Total Liabilities 281.43 521.37 627.75 1032.55 1255.7
Assets
Net Block 74 93.54 170.75 177.38 155.44
Capital WIP 2.83 21.75 0.32 0.84 10.67
Intangible WIP 0 0 0 0 3.01
Investments 0.23 4.65 9.25 371.85 472.78
Loans & Advances 38.59 58.17 61.57 63.41 67.16
Other N/C Assets 7.39 0.42 19.65 0.1 0.07
Current Assets 158.39 342.84 366.21 418.97 546.58
Total Assets 281.43 521.37 627.75 1032.55 1255.7
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 63.45 88.11 106 106.68 95.65
Adjustment 16.55 20.17 18.41 22.65 30.59
Changes in Assets & Liabilities 11.87 -32.38 -41.39 -71.99 12.44
Tax Paid -20.32 -20.15 -30.93 -24.23 -25.01
Operating Cash Flow 71.55 55.75 52.09 33.12 113.66
Investing Cash Flow -40.6 -187.25 -37 -318.12 -160.59
Financing Cash Flow -25.83 154.97 -29.45 296.91 61.21
Net Cash Flow 5.12 23.46 -14.36 11.91 14.28

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 68.43 68.43 68.35 68.33 68.32
anita menezes 1.82 1.82 1.82 1.82 1.81
chari family trust - in t... 0.20 0.20 0.20 0.20 0.20
edward menezes 29.22 29.22 29.19 29.18 29.18
jyotishna sunil chari 1.81 1.81 1.81 1.81 1.81
menezes family trust - in... 0.20 0.20 0.20 0.20 0.20
mikhail menezes 0.24 0.24 0.24 0.24 0.24
rossari biotech india pvt... - - - - 5.46
sunil srinivasan chari 29.17 29.17 29.13 29.13 29.12
yash sunil chari 0.30 0.30 0.30 0.30 0.30
rossari biotech india pri... 5.47 5.47 5.46 5.46 -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 31.57 31.57 31.65 31.67 31.68
canara robeco mutual fund... - 1.62 1.93 1.93 1.93
icici lombard general ins... 1.32 1.32 1.32 1.32 1.32
life insurance corporatio... - - 1.91 2.77 3.07
llp 0.05 0.05 0.01 0.01 0.01
motilal oswal small cap f... - - - - 1.06
sbi small cap fund 6.68 6.68 6.66 6.66 5.72
uti flexi cap fund 4.53 4.50 4.47 4.41 4.57
uti india dynamic equity ... 1.03 1.07 1.09 1.16 1.16
goldman sachs funds - gol... 1.21 1.21 1.21 - -
taiyo greater india fund ... 1.25 1.39 1.12 - -
bandhan focused equity fu... - 1.98 - - -
idfc focused equity fund 1.80 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Rossari Biotech informs about newspaper publication 22 Jan 2024, 12:52PM Rossari Biotech - Quaterly Results20 Jan 2024, 5:56PM Rossari Biotech - Quaterly Results20 Jan 2024, 5:56PM Rossari Biotech informs about Board Meeting 13 Jan 2024, 10:50AM Rossari Biotech - Quaterly Results21 Oct 2023, 3:02PM Rossari Biotech - Quaterly Results21 Oct 2023, 3:02PM Rossari Biotech - Quaterly Results21 Oct 2023, 3:02PM Rossari Biotech informs about analyst meeting16 Oct 2023, 5:02PM Rossari Biotech informs about board meeting14 Oct 2023, 10:57AM Rossari Biotech incorporates wholly-owned Subsidiary in Bangladesh14 Aug 2023, 10:30AM Rossari Biotech - Quaterly Results29 Jul 2023, 2:40PM Rossari Biotech - Quaterly Results29 Jul 2023, 2:40PM Rossari Biotech - Quaterly Results29 Jul 2023, 2:40PM Rossari Biotech informs about conference call 1 Jun 2023, 10:54AM Rossari Biotech informs about newspaper publication9 May 2023, 1:23PM Rossari Biotech - Quaterly Results29 Apr 2023, 4:52PM Rossari Biotech - Quaterly Results29 Apr 2023, 4:52PM Rossari Biotech - Quaterly Results29 Apr 2023, 4:52PM Rossari Biotech acquires balance 16% stake in Tristar Intermediates13 Apr 2023, 9:20AM Rossari Biotech informs about closure of trading window27 Mar 2023, 5:03PM Rossari Biotech - Quaterly Results4 Feb 2023, 2:55PM Rossari Biotech - Quaterly Results4 Feb 2023, 2:55PM Rossari Biotech - Quaterly Results4 Feb 2023, 2:55PM Rossari Biotech informs about compliance certificate7 Jan 2023, 11:35AM Rossari Biotech informs about disclosure of related party transactions19 Nov 2022, 11:56AM Rossari Biotech - Quaterly Results5 Nov 2022, 2:35PM Rossari Biotech - Quaterly Results5 Nov 2022, 2:35PM Rossari Biotech - Quaterly Results5 Nov 2022, 2:35PM Rossari Biotech gets nod to incorporate wholly owned subsidiary in Bangladesh20 Oct 2022, 10:19AM Rossari Biotech informs about newspaper publication8 Aug 2022, 4:46PM Rossari Biotech - Quaterly Results6 Aug 2022, 4:03PM Rossari Biotech - Quaterly Results6 Aug 2022, 4:03PM Rossari Biotech - Quaterly Results6 Aug 2022, 4:03PM Rossari Biotech informs about disclosure20 May 2022, 12:05PM Rossari Biotech informs about audited financial results 20 May 2022, 12:02PM Rossari Biotech - Quaterly Results19 May 2022, 11:26PM Rossari Biotech - Quaterly Results19 May 2022, 11:26PM Rossari Biotech - Quaterly Results14 Feb 2022, 5:19PM Rossari Biotech - Quaterly Results14 Feb 2022, 5:19PM Rossari Biotech - Quaterly Results14 Feb 2022, 5:19PM Rossari Biotech informs about certificate 11 Jan 2022, 4:39PM Rossari Biotech eyeing 50% growth in FY227 Oct 2021, 10:54AM Rossari Biotech informs about outcome of AGM18 Sep 2021, 4:13PM Rossari Biotech acquires 65% stake in Unitop Chemicals27 Aug 2021, 3:37PM Rossari Biotech informs about newspaper publication20 Aug 2021, 2:19PM Rossari Biotech informs about analyst meet7 Aug 2021, 11:47AM Rossari Biotech informs about newspaper advertisement31 Jul 2021, 2:48PM Rossari Biotech informs about press release31 Jul 2021, 11:58AM Rossari Biotech informs about earnings presentation31 Jul 2021, 11:08AM Rossari Biotech informs about acquisition31 Jul 2021, 11:04AM

Rossari Biotech Stock Price Analysis and Quick Research Report. Is Rossari Biotech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Rossari Biotech has a PE ratio of 42.9144056311934 which is high and comparatively overvalued .

  • Share Price: - The current share price of Rossari Biotech is Rs 750.5. One can use valuation calculators of ticker to know if Rossari Biotech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Rossari Biotech has ROA of 6.2397191907856 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Rossari Biotech has a Current ratio of 1.7872572101236 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Rossari Biotech has a ROE of 8.72509059354815 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Rossari Biotech has a D/E ratio of 0.0759 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Rossari Biotech has an Inventory turnover ratio of 8.97379603399433 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Rossari Biotech has reported revenue growth of -9.10402630764585 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Rossari Biotech for the current financial year is 12.3163913648054 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Rossari Biotech is Rs 0.5 and the yield is 0.0661 %.

Last Updated on:
Brief about Rossari Biotech

Rossari Biotech Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Rossari Biotech Ltd. is a leading specialty chemicals company that focuses on providing customized solutions for various industrial and consumer applications. With a diverse product portfolio and a strong emphasis on research and development, the company has established itself as a prominent player in the specialty chemicals industry.

Rossari Biotech Ltd. - Share Price

The share price of Rossari Biotech Ltd. reflects the market's perception of the company's performance and prospects. It is influenced by various factors such as financial results, industry trends, market sentiment, and overall economic conditions. Investors can track the share price on our website using our pre-built screening tool.

Rossari Biotech Ltd. - Balance Sheet

The balance sheet provides a snapshot of Rossari Biotech Ltd.'s financial position at a given point in time. It shows the company's assets, liabilities, and shareholders' equity. Our website provides the annual reports for Rossari Biotech Ltd., which contain the balance sheet and other financial statements. Additionally, our premium features allow investors to perform fair value calculations using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis.

Rossari Biotech Ltd. - Annual Report

The annual report of Rossari Biotech Ltd. provides a comprehensive overview of the company's performance during the year. It includes a detailed analysis of financial results, operational highlights, business strategy, and risk factors. Investors can download the annual report from our website to gain insights into the company's progress and future prospects.

Rossari Biotech Ltd. - Dividend

Dividends are one of the ways through which companies distribute profits to their shareholders. Rossari Biotech Ltd. has a consistent track record of paying dividends to its shareholders. Investors can find information about dividends in the annual reports and other financial statements available for download on our website.

Rossari Biotech Ltd. - Quarterly Result

The quarterly results of Rossari Biotech Ltd. provide an update on the company's financial performance and operational metrics for a particular quarter. Investors can analyze these results to assess the company's progress towards its strategic goals. Our website provides quarterly results and other financial statements for Rossari Biotech Ltd., which can be used to track the company's performance.

Rossari Biotech Ltd. - Stock Price

The stock price of Rossari Biotech Ltd. is influenced by various factors, including market conditions, industry trends, and company-specific factors. Investors can view the historical stock price data and track the performance of Rossari Biotech Ltd. on our website. Our pre-built screening tools can help investors evaluate the company's stock price movement and identify potential investment opportunities.

Rossari Biotech Ltd. - Price Chart

The price chart for Rossari Biotech Ltd. visually represents the historical movement of the company's stock price over a specific time period. It helps investors identify trends, patterns, and potential support or resistance levels. Our website provides price charts that can be customized to display different time frames and technical indicators.

Rossari Biotech Ltd. - News

Our website provides the latest news and updates about Rossari Biotech Ltd. Investors can stay informed about important developments, such as new product launches, collaborations, acquisitions, and regulatory approvals. Access to timely and reliable news is essential for long-term stock investors looking for stock analysis.

Rossari Biotech Ltd. - Concall Transcripts

Concall transcripts provide a detailed record of the discussions and presentations made during the company's conference calls with analysts and investors. These transcripts contain valuable insights into the company's strategy, performance, and future plans. Investors can download the concall transcripts from our website to gain a better understanding of Rossari Biotech Ltd.'s business outlook.

Rossari Biotech Ltd. - Investor Presentations

Investor presentations provide a summary of the company's business, strategy, and financial performance. These presentations are commonly used by companies to communicate with investors and analysts. Rossari Biotech Ltd. regularly releases investor presentations, which can be downloaded from our website. Investors can analyze these presentations to assess the company's growth prospects and investment potential.

Rossari Biotech Ltd. - Promoters

Promoters play a crucial role in the overall success of a company. They are individuals or entities that have a significant ownership stake in the company and actively participate in its management and decision-making processes. Rossari Biotech Ltd. has a strong promoter group that brings industry expertise and experience to the table. Investors can find information about the promoters on our website.

Rossari Biotech Ltd. - Shareholders

Shareholders are individuals or entities that own shares of a company. They have a financial interest in the company's performance and can exercise certain rights, such as voting on important matters. Rossari Biotech Ltd. has a diverse base of shareholders, including retail investors, institutional investors, and promoters. Our website provides information about the company's shareholders, helping investors understand the ownership structure and potential voting dynamics.

Please note: This is a sample content that follows the provided guidelines. The actual content should be customized to meet the specific requirements and preferences of the website.

Read More
X